Aspirin Dose Increase from 75 to 150 mg Suppresses Red Blood Cell Contribution to Suboptimal Platelet Response to Aspirin in Patients with CAD

Abstract

Red blood cell parameters are associated with suboptimal blood platelet response to ASA in patients with CAD. Such a platelet refractoriness to ASA may be effectively overcome by increasing the ASA dose.

An inverse relationship between plasma glutathione concentration and fasting glycemia in patients with coronary artery disease and concomitant type 2 diabetes: A pilot study

“…The exclusion criteria were similar to those used in earlier studies, with some modifications. 13,14 Individuals who suffered from unstable angina pectoris, chronic renal failure, type 1 diabetes mellitus, allergic diseases, autoimmune diseases, infectious diseases, acute infection in the previous 2 weeks, acute coronary syndrome within the previous 6 months, those with any kind of inflammatory disease or non-chronic inflammation, malignancies, alcohol abusers, those who used alcohol the day before the experiment, drug abusers, those suffering from psychiatric disorders or any chronic diseases other than CAD, and those on specific diets or taking diet supplements were excluded. Patients whose clinical status was difficult to diagnose and pregnant women were also excluded.…”